Most patients (68%) had low risk prostate cancer according to D’Amico stratification system; 83.6% had Gleason score 6 or less, 84.6% had initial PSA less than or equal to 10 ng/ml and 94% clinical stage T1c and T2a. This evidence concerns the gene KLK3 and prostate carcinoma.